Efficacy of Turmeric as Adjuvant Therapy in Type 2 Diabetic Patients

Indian Journal of Clinical Biochemistry

Volumn 30, Issue 2, 2015, Pages 180-186

  Maithili Karpaga Selvi, N ^a   Sridhar, M G ^a   Swaminathan, R P ^a   Sripradha, R ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Diabetes; Dyslipidemia; Inflammation; Malondialdehyde; Metformin; Turmeric

Indexed keywords

EID: 84939883382     PISSN: 09701915     EISSN: 09740422     Source Type: Journal    
DOI: 10.1007/s12291-014-0436-2     Document Type: Article

References (34)

1. Wild S, Roglic G, Green A. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.
2. Nicholas SB. Lipid disorders in obesity. Curr Hypertens Rep. 1999;1:131–6.
3. Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal. 2005;7:1040–52.
4. Rowais NA. Herbal medicine in the treatment of diabetes mellitus. Saudi Med J. 2002;23:1327–31.
5. Shishodia S, Sethi G, Aggarwal B. Curcumin: getting back to the roots. Ann NY Acad Sci. 2005;1056:206–17.
6. Khopde SM, Priyadarsini P, Venkatesan, et al. Free radical scavenging ability and antioxidant efficiency of curcumin and its substituted analogue. Biophys Chem. 1999;80:85–9.
7. Aggarwal BB, Kumar A, Harti ACB. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003;23:363–98.
8. Stuart P. Dietary circumin significantly improves obesity associated inflammation and diabetes in mouse models of diabesity. J Endocrinol. 2008;149(7):3549–58.
9. Wickenberg J. Effects of Curcuma longa (turmeric) on postprandial plasma glucose and insulin in healthy subjects. Nutr J. 2010;9:43.
10. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
11. Matthews DR, Hosker JP, Rudenski AS. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.
12. Beutler E, Duron OM, Kelly B. Improved method for determination of blood glutathione. J Lab Clin Med. 1963;61:882–8.
13. Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121–6.
14. Yagi K. Assay for blood, plasma or serum lipid peroxides. Methods Enzymol. 1984;105:28–31.
15. Iris F, Benzie F. The ferric reducing ability of plasma (FRAP) as a measure of ‘‘antioxidant power’’: the FRAP assay. Anal Biochem. 1996;239:70–6.
16. Reznick AZ, Packer L. Oxidative damage to protein: spectrophotometric method for carbonyl assay. Methods Enzymol. 1994;233:357–63.
17. Wendel A. Glutathione peroxidase. Methods Enzymol. 1981;77:325–33.
18. Parviz K. Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-b and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study. Scand J Urol Nephrol. 2011;45:365–70.
19. Fujiwara H. Curcumin inhibits glucose production in isolated mice hepatocytes. Diabetes Res Clin Pract. 2000;80:185–90.
20. Sushil K, Justin R, Kimberly J. Effect of curcumin on protein glycosylation, lipid peroxidation, and oxygen radical generation in human red blood cells exposed to high glucose levels. Free Radic Biol Med. 2006;41(1):92–6.
21. Griesmacher A, Kindhauser M, Andert SE. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med. 1995;98:475–96.
22. Sekeroglu H, Sahin H. The effect of dietary treatment on erythrocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase, and serum lipid peroxidation in patients with type 2 diabetes mellitus. Clin Biochem. 2000;33:669–74.
23. Sreejayan Rao MN. Curcuminoids as potent inhibitors of lipid peroxidation. J Pharm Pharmacol. 1994;46:1013–6.
24. Masuda T, Maekawa T. Chemical studies on antioxidant mechanisms of curcumin: analysis of oxidative coupling products from curcumin and linoleate. J Agric Food Chem. 2001;49:2539–47.
25. Arun N. Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods Hum Nutr. 2002;57:41–52.
26. Assmann G, Schulte H. The prospective cardiovascular munster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J. 1988;116:1713–24.
27. Ramirez Bosca A, Soler A, Carrion-Gutierrez MA. An hydroalcoholic extract of Curcuma longa lowers the abnormally high values of human-plasma fibrinogen. Mech Ageing Dev. 2000;114(3):207–10.
28. Tortosa MC, Mesa MD, Aguilera MC. Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis. Atherosclerosis. 1999;147:371–8.
29. Corrado E, Rizzo M, Muratori I, Coppola G, Novo S. Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in patients with newly diagnosed hypertension or type II diabetes. Arch Med Res. 2006;37:1004–9.
30. Ahmad J, Ahmed F, Siddiqui MA. Inflammatory markers, insulin resistance and carotid intima-media thickness in North-Indian type 2 diabetic subjects. J Assoc Physicians India. 2007;55:693–9.
31. Farah R, Shurtz-Swirski R, Lapin O. Intensification of oxidative stress and inflammation in type 2 diabetes despite antihyperglycemic treatment. Cardiovasc Diabetol. 2008;22:7–20.
32. Huang MT, Lysz T, Ferraro T. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. 1991;51:813–9.
33. Chun KS, Keum YS, Han SS, Song YS, Kim SH, Surh YJ. Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation. Carcinogenesis. 2003;24:1515–24.
34. Lee KW, Kim JH, Lee HJ, Surh YJ. Curcumin inhibits phorbol ester-induced upregulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-kappaB transcriptional activity in MCF10A human breast epithelial cells. Antioxid Redox Signal. 2005;7:1612–20.